(+)-Abscisic Acid

Key Product Details

Product Description

(+)-Abscisic Acid is an endogenous lanthionine synthetase C-like 2 (LANCL2) ligand. Stimulates glucose uptake by myocytes and pre-adipocytes in vitro, and by brown adipose tissue in vivo. Acts as a pro-inflammatory modulator of innate immune system cells. Stimulates proliferation of human mesenchymal and hematopoietic stem cells. Also used to control Cas9 via a RNA polymerase-based biosensor.

Product Specifications for (+)-Abscisic Acid

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Solubility

Preparing Stock Solutions for (+)-Abscisic Acid

The following data is based on the product molecular weight 264.32.

Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:

1 Recalculate

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	3.78 mL	18.92 mL	37.83 mL
5 mM	0.76 mL	3.78 mL	7.57 mL
10 mM	0.38 mL	1.89 mL	3.78 mL
50 mM	0.08 mL	0.38 mL	0.76 mL

Calculators

Background References

References are publications that support the biological activity of the product. See our Citations tab to view 7 publications citing the usage of this product.

• Pu Multidimensional control of Cas9 by evolved RNA polymerase-based biosensors. ACS Chem.Biol. 2018 PMID: 28809467
• Fresia G-protein coupling and nuclear translocation of the human abscisic acid receptor LANCL2. Sci.Rep. 2016 PMID: 27222287
• Sturla Abscisic acid enhances glucose disposal and induces brown fat activity in adipocytes in vitro and in vivo. Biochim.Biophys.Acta. 2017 PMID: 27871880
• Carbo An N,N-Bis(benzimidazolylpicolinoyl)piperazine (BT-11): A novel lanthionine synthetase C-Like 2-based therapeutic for inflammatory bowel disease. J.Med.Chem. 2016 PMID: 27933891

Product Documents for (+)-Abscisic Acid